Published in Inflamm Bowel Dis on March 01, 2016
Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science (2006) 6.47
A developmental perspective on alcohol and youths 16 to 20 years of age. Pediatrics (2008) 4.32
Genome-wide functional analysis of human cell-cycle regulators. Proc Natl Acad Sci U S A (2006) 2.31
Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res (2008) 2.13
Increased immune reactivity predicts aggressive complicating Crohn's disease in children. Clin Gastroenterol Hepatol (2008) 2.09
Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease. J Clin Microbiol (2008) 2.06
Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr (2005) 1.98
Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology (2003) 1.70
Reduced polyp detection as endoscopy shift progresses: experience with screening colonoscopy at a tertiary-care hospital. J Clin Gastroenterol (2011) 1.66
Challenges in pediatric inflammatory bowel disease. Inflamm Bowel Dis (2006) 1.49
C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis. J Crohns Colitis (2011) 1.47
Diet, lifestyle, and genomic instability in the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev (2005) 1.45
Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence. Addict Behav (2008) 1.41
5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomarkers Prev (2002) 1.39
Novel splice-site mutation in ATP8B1 results in atypical progressive familial intrahepatic cholestasis type 1. J Gastroenterol Hepatol (2013) 1.38
Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial. J Clin Oncol (2009) 1.35
'Inappropriate' attendance at an accident and emergency department by adults registered in local general practices: how is it related to their use of primary care? J Health Serv Res Policy (2002) 1.33
Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's disease. Clin Gastroenterol Hepatol (2006) 1.33
The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol (2006) 1.33
Social ties and colorectal cancer screening among Blacks and Whites in North Carolina. Cancer Epidemiol Biomarkers Prev (2005) 1.31
Use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease. J Pediatr Gastroenterol Nutr (2012) 1.17
Intercenter variation in initial management of children with Crohn's disease. Inflamm Bowel Dis (2007) 1.17
Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. Inflamm Bowel Dis (2008) 1.17
Rural-urban differences in colon cancer risk in blacks and whites: the North Carolina Colon Cancer Study. J Rural Health (2006) 1.16
Constipation, laxative use, and colon cancer in a North Carolina population. Am J Gastroenterol (2003) 1.16
Association of industry sponsorship to published outcomes in gastrointestinal clinical research. Clin Gastroenterol Hepatol (2006) 1.15
Why patients with inflammatory bowel disease use or do not use complementary and alternative medicine: a Canadian national survey. Can J Gastroenterol (2005) 1.15
Growth abnormalities persist in newly diagnosed children with crohn disease despite current treatment paradigms. J Pediatr Gastroenterol Nutr (2009) 1.15
Outcome following infliximab therapy in children with ulcerative colitis. Am J Gastroenterol (2010) 1.14
Long-term outcome of maintenance infliximab therapy in children with Crohn's disease. Inflamm Bowel Dis (2009) 1.13
Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease. Inflamm Bowel Dis (2010) 1.13
Underage alcohol use: summary of developmental processes and mechanisms: ages 16-20. Alcohol Res Health (2009) 1.13
Laboratory values for children with newly diagnosed inflammatory bowel disease. Pediatrics (2007) 1.10
Intake of polyunsaturated fatty acids and distal large bowel cancer risk in whites and African Americans. Am J Epidemiol (2010) 1.05
Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology? Inflamm Bowel Dis (2009) 1.03
Race and colorectal cancer screening: a population-based study in North Carolina. N C Med J (2004) 1.02
Challenges and strategies of children and adolescents with inflammatory bowel disease: a qualitative examination. Health Qual Life Outcomes (2007) 1.01
Appraisal of the pediatric Crohn's disease activity index on four prospectively collected datasets: recommended cutoff values and clinimetric properties. Am J Gastroenterol (2010) 1.01
Alcohol use frequency as a screen for alcohol use disorders in adolescents. Int J Adolesc Med Health (2006) 1.01
Increased risk of pneumonia among patients with inflammatory bowel disease. Am J Gastroenterol (2013) 1.00
Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr (2007) 0.99
Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions. Inflamm Bowel Dis (2011) 0.98
Dietary patterns and colon cancer risk in Whites and African Americans in the North Carolina Colon Cancer Study. Nutr Cancer (2009) 0.98
Course and treatment of perianal disease in children newly diagnosed with Crohn's disease. Inflamm Bowel Dis (2009) 0.97
Psychosocial issues in the child with chronic conditions. Best Pract Res Clin Gastroenterol (2003) 0.95
Gastric cancer incidence estimation in a resource-limited nation: use of endoscopy registry methodology. Cancer Causes Control (2012) 0.89
Physician attitudes and practices of enteral nutrition as primary treatment of paediatric Crohn disease in North America. J Pediatr Gastroenterol Nutr (2011) 0.89
Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study. Am J Gastroenterol (2011) 0.87
Apoptosis in normal rectal mucosa, baseline adenoma characteristics, and risk of future adenomas. Cancer Epidemiol Biomarkers Prev (2008) 0.87
Use of nonsteroidal antiinflammatory drugs and distal large bowel cancer in whites and African Americans. Am J Epidemiol (2008) 0.86
Functional health literacy, chemotherapy decisions, and outcomes among a colorectal cancer cohort. Cancer Control (2015) 0.86
Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitis. J Pediatr Gastroenterol Nutr (2013) 0.85
DNase I footprinting of small molecule binding sites on DNA. Methods Mol Biol (2005) 0.85
At-line bioprocess monitoring by immunoassay with rotationally controlled serial siphoning and integrated supercritical angle fluorescence optics. Anal Chim Acta (2013) 0.84
Roles of religious involvement and social support in the risk of colon cancer among Blacks and Whites. Am J Epidemiol (2003) 0.84
Assessment of serum proteomics to detect large colon adenomas. Cancer Epidemiol Biomarkers Prev (2008) 0.83
Which PCDAI Version Best Reflects Intestinal Inflammation in Pediatric Crohn Disease? J Pediatr Gastroenterol Nutr (2017) 0.82
Low prevalence of Helicobacter pylori infection in Canadian children: a cross-sectional analysis. Can J Gastroenterol (2008) 0.81
Budesonide in the treatment of inflammatory bowel disease. Expert Rev Clin Immunol (2011) 0.79
Health-related quality of life in pediatric ulcerative colitis patients on conventional medical treatment compared to those after restorative proctocolectomy. Int J Colorectal Dis (2012) 0.78
Tea intake and risk of colon cancer in African-Americans and whites: North Carolina colon cancer study. Cancer Causes Control (2003) 0.78
Increased risk of pneumocystis jiroveci pneumonia among patients with inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.78
An autosomal recessive form of Alagille-like syndrome that is not linked to JAG1. Genet Med (2007) 0.78
Risk factors for advanced disease in colorectal cancer. Am J Gastroenterol (2004) 0.77
Development and validation of a pediatric IBD knowledge inventory device: the IBD-KID. J Pediatr Gastroenterol Nutr (2014) 0.77
Retrospective cohort study of methotrexate use in the treatment of pediatric Crohn's disease. Inflamm Bowel Dis (2014) 0.77
Campylobacter concisus: a new character in the Crohn's disease story? J Clin Microbiol (2009) 0.76
Response: an insidious dependence. Addict Sci Clin Pract (2007) 0.75
Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers. Inflamm Bowel Dis (2016) 0.75
Evaluating health utilities in adolescents: raising the profile of an alternative method for assessing health-related quality of life. J Pediatr (2009) 0.75
Cost and outcome analyses on the timing of first independent medical evaluation in patients with work-related lumbosacral sprain. J Occup Environ Med (2007) 0.75
In situ observation of homogeneous nucleation of nanosized zeolite A. Phys Chem Chem Phys (2006) 0.75
Olanzapine-associated Edema Decreasing Serum Lithium Concentrations: A Case Report. J Clin Psychopharmacol (1) 0.75
Revisiting infant gastroesophageal reflux disease guidelines: considering obesity. J Pediatr Gastroenterol Nutr (2014) 0.75
Item Generation and Reduction Toward Developing a Patient-reported Outcome for Pediatric Ulcerative Colitis (TUMMY-UC). J Pediatr Gastroenterol Nutr (2017) 0.75
Complementary and alternative medicine in inflammatory bowel disease: keeping an open mind. Expert Rev Clin Immunol (2005) 0.75
Perfect polar stacking of parallel beloamphiphile layers. Synthesis, structure and solid-state optical properties of the unsymmetrical acetophenone azine DCA. Dalton Trans (2006) 0.75
An Integrated Circuit for Chip-Based Analysis of Enzyme Kinetics and Metabolite Quantification. IEEE Trans Biomed Circuits Syst (2016) 0.75
DIABETIC KETOACIDOSIS CRITICAL CARE PATHWAY IMPLEMENTATION: INCORPORATION INTO EMR SIGNIFICANTLY DECREASES LENGTH OF STAY. Endocr Pract (2016) 0.75